Skip to content

Clinical trials

Scleroderma, Systemic trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Systemic Country / region: Poland Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20082
20101
20111
20121
20152
20162
20181
20201
20211
20222
20232
20241
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting4
Terminated4
Active, not recruiting3
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim3
Actelion2
Amgen2
ISDIN2
Artiva Biotherapeutics, Inc.1
AstraZeneca1
Bristol-Myers Squibb1
Celgene1
Certa Therapeutics1
EMD Serono Research & Development Institute, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Systemic25
Scleroderma, Diffuse8
Lung Diseases, Interstitial6
Autoimmune Diseases4
Arthritis, Rheumatoid3
Dermatomyositis3
Lupus Erythematosus, Systemic3
Myositis3
Sjogren's Syndrome3
Hypertension, Pulmonary2

Trials

Showing 51 to 25 of 25. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.